Trial Profile
Effects on heart rate of three different up-titration regimens of ponesimod, a selective S1P1 receptor modulator, and of re-initiation of treatment in healthy male and female subjects
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Nov 2015
Price :
$35
*
At a glance
- Drugs Ponesimod (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 25 Jun 2015 Data will be presented at the 12th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT 2015), according to an Actelion Pharmaceuticals media release.
- 01 Dec 2012 New trial record